Cutler Group LP Atara Biotherapeutics, Inc. Call Options Transaction History

Cutler Group LP

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Jul 18, 2023	BUY	$1.5 - $3.04 $25,350 - $51,376	16,900 Added 272.58%	23,100 $12,000
Q1 2023 May 01, 2023	BUY	$2.8 - $5.46 $17,360 - $33,852	6,200 New	6,200 $4,000
Q1 2022 Apr 14, 2022	BUY	$8.44 - $16.89 $98,748 - $197,613	11,700 Added 780.0%	13,200 $7,000
Q3 2020 Oct 27, 2020	BUY	$11.92 - $15.87 $9,536 - $12,696	800 Added 114.29%	1,500 $1,000
Q2 2020 Jul 22, 2020	SELL	$7.53 - $14.93 $753 - $1,493	-100 Reduced 12.5%	700 $1,000

Q1 2020 May 07, 2020	BUY	$5.69 - $17.78 $4,552 - $14,224	800 New	800 $0
Q4 2019 Feb 06, 2020	SELL	$10.89 - $16.79 $217,800 - $335,800	-20,000 Closed	0 $0
Q3 2019 Oct 28, 2019	SELL	$12.03 - $19.94 $400,599 - $664,002	-33,300 Reduced 62.48%	20,000 $8,000
Q2 2019 Aug 09, 2019	BUY	$19.05 - $41.04 $1.02 Million - $2.19 Million	53,300 New	53,300 $64,000
Q1 2019 May 10, 2019	SELL	$28.4 - $41.74 $284,000 - $417,400	-10,000 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$30.9 - $42.97 $126,690 - $176,177	-4,100 Reduced 29.08%	10,000 $29,000
Q3 2018 Nov 07, 2018	SELL	$35.05 - $43.5 $346,995 - $430,650	-9,900 Reduced 41.25%	14,100 $78,000
Q2 2018 Aug 10, 2018	SELL	$35.15 - $51.45 $1.59 Million - $2.33 Million	-45,300 Reduced 65.37%	24,000 $73,000
Q1 2018 May 11, 2018	BUY	$18.0 - $48.35 $1.24 Million - $3.34 Million	69,000 Added 23000.0%	69,300 $130,000
Q3 2017 Oct 17, 2017	BUY	$13.25 - $17.05 $3,975 - $5,115	300	300 $0

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.